BEDFORD, Mass., March 3, 2014 /PRNewswire/ -- Hologic, Inc.
(Hologic or the Company) (Nasdaq: HOLX), a leading developer,
manufacturer and supplier of premium diagnostic products, medical
imaging systems and surgical products, with an emphasis on serving
the healthcare needs of women, will showcase its extensive
portfolio of innovative products for breast cancer screening and
diagnosis, breast biopsy, osteoporosis risk assessment, and
extremity imaging at the annual meeting of the European Society of
Radiology, in Vienna, Austria
March 6th through 10th. The European
Congress of Radiology (ECR), the largest medical imaging meeting in
Europe, annually attracts over
20,000 participants representing the medical specialty of radiology
throughout Europe and many other
countries of the world.
"ECR will be a particularly exciting time for us to showcase our
total breast tomosynthesis solution to the radiology world," said
David Harding, Hologic's Group
Senior Vice President and General Manager, Women's Health. "The
growing number of peer-reviewed clinical publications confirming
the efficacy of our C-View software as a lower-dose alternative for
tomosynthesis exams, coupled with the strong performance of our
tomosynthesis biopsy option for the Affirm breast biopsy guidance
system, strengthens our position as the only provider of a complete
3D package for screening, diagnostic and interventional
applications. This meeting provides an excellent opportunity to
highlight why our tomosynthesis technology is gaining widespread
acceptance based on its ability to detect invasive breast cancers
earlier and decrease anxiety-provoking recalls while offering a
versatile platform for advanced applications."
To further highlight the advances in its breast tomosynthesis
technology, Hologic is offering three special tomosynthesis-related
events at ECR:
- A special ECR Satellite Symposium, "Breast Tomosynthesis:
Evolution and Adoption Across Europe," on Saturday, March 8 from 2:00 to 3:30 p.m. in the Austria Center Vienna,
Room C. The symposium will feature speakers from various
countries throughout Europe,
including:
Fiona Gilbert, Cambridge, United Kingdom - The use of breast
tomosynthesis in the screening assessment in the UK.
Melcior Sentis, Sabadell, Spain - Using breast
tomosynthesis with C-View 2D images and tomosynthesis guided
biopsy: our experience in Spain.
Francesca Caumo, Verona,
Italy - Diagnostic and interventional use of breast
tomosynthesis: our experience in Italy.
Martin Sonnenschein, Bern, Switzerland - The use of breast
tomosynthesis with C-View images and tomosynthesis guided biopsy in
daily practice: our experience in Switzerland.
Per Skaane, Oslo, Norway -
Incorporating breast tomosynthesis in a population-based screening
program: our experience in Oslo.
- Eight 75-minute breast tomosynthesis education sessions from
March 7th through the 9th. Each
session includes hands-on experience reading breast tomosynthesis
images in combination with conventional and generated (C-View) 2D
images.
- Fourteen breast biopsy guided by tomosynthesis training
workshops from March 7th through the
9th. Each workshop will include an overview of the first clinical
experiences with vacuum-assisted breast biopsies guided by
tomosynthesis prior to a demonstration of a phantom procedure.
There will be time at the end of each session for hands-on
training.
For additional information and registration information, please
email Tomoinfo@hologic.com.
Other Leading-edge Products on Display:
Horizon Bone Densitometry (DXA) System. Shown for the
first time in Europe, Hologic's
Horizon DXA system provides a single platform for osteoporosis and
obesity assessment, visualization of abdominal aortic
calcifications and an innovative new feature enabling atypical
femur fracture assessment.
Selenia Dimensions Avia Package. A cost-effective option
for customers seeking a 2D screening only or 2D screening and
diagnostic solution, this package provides an upgrade pathway for
interventional and tomosynthesis capabilities.
Fluoroscan InSight-FD Mini C-arm. Featuring flat
panel detector technology, this system is designed specifically for
orthopedic and extremity surgeons and offers a thin profile and
improved workspace access with enhanced ease of positioning.
Breast Biopsy Systems. Hologic's Eviva and
ATEC breast biopsy systems are designed to conduct minimally
invasive biopsy procedures under stereotactic, ultrasound, or MRI
guidance.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier
of premium diagnostic products, medical imaging systems and
surgical products. The Company operates four core business units
focused on breast health, diagnostics, GYN surgical, and skeletal
health. With a comprehensive suite of technologies and a robust
research and development program, Hologic is committed to improving
lives. The Company is headquartered in Massachusetts. For more information, visit
www.hologic.com.
Hologic, Affirm, ATEC, C-View, Dimensions, Eviva, Fluoroscan,
Horizon and Selenia are trademarks and/or registered trademarks of
Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Forward-looking Statement Disclaimer:
This News Release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein and that such benefits
will be replicated in any particular manner with respect to an
individual patient as the actual effect of the use of the products
can only be determined on a case-by-case basis depending on the
particular circumstances and patient in question. Hologic expressly
disclaims any obligation or undertaking to release publicly any
updates or revisions to any such statements presented herein to
reflect any change in expectations or any change in events,
conditions or circumstances on which any such data or statements
are based.
Contacts:
Pat Hall
|
Marianne
McMorrow
|
Director of Corporate
Communications
|
Global PR and
Advertising Manager
|
pat.hall@hologic.com
|
marianne.mcmorrow@hologic.com
|
781.999.7463
(Boston)
|
781.999.7723
(Boston)
|
919.245.3460 (North
Carolina)
|
512.284.4424
(mobile)
|
919.622.1341
(mobile)
|
|
SOURCE Hologic, Inc.